Daniel Hansen is molecular biologist with expert skills at the bench. He has been part of the Ravnskjaer-group since 2018 and conducted his PhD study on the topic of hepatic stellate cell (HSC) function, lipid metabolism, and metabolic liver disease (MASLD/MASH) in the Ravnskjaer-group from 2020-2023. He has been involved in several projects on the liver's transcriptional regulation placing special focus on liver sinusoidal cells and their role in MASH and fibrosis development.
Daniel became a Danish Diabetes Academy-funded PhD fellow affiliated with ATLAS in September 2020, and is now a postdoc in the Ravnskjaer-group. He seeks the understanding of MASLD progression and HSC function by studying mouse and human liver and gauge the implication and expression of G-protein coupled receptors (GPCRome) by applying state-of-the-art technologies, including next-generation sequencing, single-cell transcriptomics, and histological interrogations to gain fruitful insights into liver metabolism, disease development, and the involved liver stellate cell GPCRome.
